ArticleKidney international reports2024

Pilot Trial of Hydroxychloroquine as Add-On Therapy in Patients With Membranous Nephropathy.

Hongyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.